Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Prognostic Factors and Treatment Outcomes of Adult Patients With Rhabdomyosarcoma After Multimodality Treatment.

Liu YT, Wang CW, Hong RL, Kuo SH.

Anticancer Res. 2019 Mar;39(3):1355-1364. doi: 10.21873/anticanres.13249.

PMID:
30842169
2.

Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer.

Kishan AU, Dang A, Katz AJ, Mantz CA, Collins SP, Aghdam N, Chu FI, Kaplan ID, Appelbaum L, Fuller DB, Meier RM, Loblaw DA, Cheung P, Pham HT, Shaverdian N, Jiang N, Yuan Y, Bagshaw H, Prionas N, Buyyounouski MK, Spratt DE, Linson PW, Hong RL, Nickols NG, Steinberg ML, Kupelian PA, King CR.

JAMA Netw Open. 2019 Feb 1;2(2):e188006. doi: 10.1001/jamanetworkopen.2018.8006.

3.

A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell Killing.

Lizotte PH, Hong RL, Luster TA, Cavanaugh ME, Taus LJ, Wang S, Dhaneshwar A, Mayman N, Yang A, Kulkarni M, Badalucco L, Fitzpatrick E, Kao HF, Kuraguchi M, Bittinger M, Kirschmeier PT, Gray NS, Barbie DA, Jänne PA.

Cancer Immunol Res. 2018 Dec;6(12):1511-1523. doi: 10.1158/2326-6066.CIR-18-0193. Epub 2018 Sep 21.

PMID:
30242021
4.

Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Survival and Toxicity Endpoints.

Meier RM, Bloch DA, Cotrutz C, Beckman AC, Henning GT, Woodhouse SA, Williamson SK, Mohideen N, Dombrowski JJ, Hong RL, Brachman DG, Linson PW, Kaplan ID.

Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):296-303. doi: 10.1016/j.ijrobp.2018.05.040. Epub 2018 Jun 1.

5.
6.

Ste20-like kinase is upregulated in glioma and induces glioma invasion.

Wang K, Hong RL, Lu JB, Wang DL.

Neoplasma. 2018;65(2):185-191. doi: 10.4149/neo_2018_170318N193.

PMID:
29534578
7.

Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study.

Cohen RB, Delord JP, Doi T, Piha-Paul SA, Liu SV, Gilbert J, Algazi AP, Damian S, Hong RL, Le Tourneau C, Day D, Varga A, Elez E, Wallmark J, Saraf S, Thanigaimani P, Cheng J, Keam B.

Am J Clin Oncol. 2018 Feb 21. doi: 10.1097/COC.0000000000000429. [Epub ahead of print]

8.

A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141.

Kiyota N, Hasegawa Y, Takahashi S, Yokota T, Yen CJ, Iwae S, Shimizu Y, Hong RL, Goto M, Kang JH, Sum Kenneth Li W, Ferris RL, Gillison M, Namba Y, Monga M, Lynch M, Tahara M.

Oral Oncol. 2017 Oct;73:138-146. doi: 10.1016/j.oraloncology.2017.07.023. Epub 2017 Sep 1.

9.

A species-specific nematocide that results in terminal embryogenesis.

Renahan T, Hong RL.

J Exp Biol. 2017 Sep 15;220(Pt 18):3238-3247. doi: 10.1242/jeb.159665. Epub 2017 Jul 6.

10.

Terminally Ill Taiwanese Cancer Patients' and Family Caregivers' Agreement on Patterns of Life-Sustaining Treatment Preferences Is Poor to Fair and Declines Over a Decade: Results From Two Independent Cross-Sectional Studies.

Liu TW, Wen FH, Wang CH, Hong RL, Chow JM, Chen JS, Chiu CF, Tang ST.

J Pain Symptom Manage. 2017 Jul;54(1):35-45.e4. doi: 10.1016/j.jpainsymman.2017.02.013. Epub 2017 Apr 24.

PMID:
28450219
11.

Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate-Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma.

Liu CW, Hua KT, Li KC, Kao HF, Hong RL, Ko JY, Hsiao M, Kuo ML, Tan CT.

Mol Cancer Ther. 2017 Jul;16(7):1421-1434. doi: 10.1158/1535-7163.MCT-16-0567-T. Epub 2017 Mar 6.

12.

Cumulative volumetric analysis as a key criterion for the treatment of brain metastases.

Kim IK, Starke RM, McRae DA, Nasr NM, Caputy A, Cernica GD, Hong RL, Sherman JH.

J Clin Neurosci. 2017 May;39:142-146. doi: 10.1016/j.jocn.2016.12.006. Epub 2017 Jan 11.

PMID:
28089195
13.

Corrigendum.

Koneru SL, Salinas H, Flores GE, Hong RL.

Mol Ecol. 2016 Dec;25(24):6267. doi: 10.1111/mec.13924. No abstract available.

PMID:
28035759
14.

Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma.

Chen JL, Huang YS, Kuo SH, Hong RL, Ko JY, Lou PJ, Wang CW.

Oncotarget. 2017 Feb 21;8(8):14068-14077. doi: 10.18632/oncotarget.12736.

15.

Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma.

Yang CW, Wang CW, Hong RL, Tsai CL, Yao M, Tang JL, Lin CW, Cheng AL, Kuo SH.

J Radiat Res. 2017 Jan;58(1):114-122. doi: 10.1093/jrr/rrw081. Epub 2016 Aug 16.

16.

The bacterial community of entomophilic nematodes and host beetles.

Koneru SL, Salinas H, Flores GE, Hong RL.

Mol Ecol. 2016 May;25(10):2312-24. doi: 10.1111/mec.13614. Epub 2016 Apr 20. Erratum in: Mol Ecol. 2016 Dec;25(24):6267.

17.

Sexual, irritative, and voiding outcomes, following stereotactic body radiation therapy for prostate cancer.

Rana Z, Hong RL, Abugideiri M, McRae D, Cernica G, Mordkin R, Joel AB, Bernstein G, Nasr NM.

Radiat Oncol. 2015 Aug 28;10:182. doi: 10.1186/s13014-015-0488-3.

18.

Comparative dosimetric findings using accelerated partial breast irradiation across five catheter subtypes.

Rana Z, Nasr NM, Ji H, Lorio V, Akbari S, Sebastian M, Martin M, Hong RL.

Radiat Oncol. 2015 Jul 31;10:160. doi: 10.1186/s13014-015-0468-7.

19.

α-Enolase-binding peptide enhances drug delivery efficiency and therapeutic efficacy against colorectal cancer.

Wu CH, Kuo YH, Hong RL, Wu HC.

Sci Transl Med. 2015 Jun 3;7(290):290ra91. doi: 10.1126/scitranslmed.aaa9391.

PMID:
26041708
20.

Dual-effect liposomes encapsulated with doxorubicin and chlorin e6 augment the therapeutic effect of tumor treatment.

Peng PC, Hong RL, Tsai YJ, Li PT, Tsai T, Chen CT.

Lasers Surg Med. 2015 Jan;47(1):77-87. doi: 10.1002/lsm.22312. Epub 2015 Jan 5.

PMID:
25559348
21.

A host beetle pheromone regulates development and behavior in the nematode Pristionchus pacificus.

Cinkornpumin JK, Wisidagama DR, Rapoport V, Go JL, Dieterich C, Wang X, Sommer RJ, Hong RL.

Elife. 2014 Oct 15;3. doi: 10.7554/eLife.03229.

22.

Conserved behavioral and genetic mechanisms in the pre-hatching molt of the nematode Pristionchus pacificus.

Lewis VM, Hong RL.

Evodevo. 2014 Sep 19;5:31. doi: 10.1186/2041-9139-5-31. eCollection 2014.

23.

Hypofractionated stereotactic body radiation therapy for elderly patients with stage IIB-IV nonsmall cell lung cancer who are ineligible for or refuse other treatment modalities.

Karam SD, Horne ZD, Hong RL, McRae D, Duhamel D, Nasr NM.

Lung Cancer (Auckl). 2014 Oct 3;5:59-66. doi: 10.2147/LCTT.S66395. eCollection 2014.

24.

Intensity-modulated radiation therapy for T4 nasopharyngeal carcinoma. Treatment results and locoregional recurrence.

Chen JL, Huang YS, Kuo SH, Chen YF, Hong RL, Ko JY, Lou PJ, Tsai CL, Chen WY, Wang CW.

Strahlenther Onkol. 2013 Dec;189(12):1001-8. doi: 10.1007/s00066-013-0429-8. Epub 2013 Oct 27.

PMID:
24158634
25.

Phase II study of TAS-106 in patients with platinum-failure recurrent or metastatic head and neck cancer and nasopharyngeal cancer.

Tsao A, Hui EP, Juergens R, Marur S, Huat TE, Cher GB, Hong RL, Hong WK, Chan AT.

Cancer Med. 2013 Jun;2(3):351-9. doi: 10.1002/cam4.79. Epub 2013 Apr 18.

26.

Robotic stereotactic body radiation therapy for elderly medically inoperable early-stage non-small cell lung cancer.

Karam SD, Horne ZD, Hong RL, Baig N, Gagnon GJ, McRae D, Duhamel D, Nasr NM.

Lung Cancer (Auckl). 2013 Aug 6;4:35-42. doi: 10.2147/LCTT.S48121. eCollection 2013.

27.

Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer.

Karam SD, Horne ZD, Hong RL, McRae D, Duhamel D, Nasr NM.

Radiat Oncol. 2013 Jul 10;8:179. doi: 10.1186/1748-717X-8-179.

28.

Identification of novel mutations of TP53, ALK and RET gene in metastatic thymic squamous cell carcinoma and its therapeutic implication.

Hu Z, Wang J, Yao T, Hong RL, Zhang K, Gao H, Wu X, Li J, Bai C, Yen Y.

Lung Cancer. 2013 Jul;81(1):27-31. doi: 10.1016/j.lungcan.2013.04.006. Epub 2013 Apr 29.

PMID:
23639785
29.

An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma.

Le QT, Zhang Q, Cao H, Cheng AJ, Pinsky BA, Hong RL, Chang JT, Wang CW, Tsao KC, Lo YD, Lee N, Ang KK, Chan AT, Chan KC.

Clin Cancer Res. 2013 Apr 15;19(8):2208-15. doi: 10.1158/1078-0432.CCR-12-3702. Epub 2013 Mar 4.

30.

Differentiated embryonic chondrocyte-expressed gene 1 is associated with hypoxia-inducible factor 1α and Ki67 in human gastric cancer.

Jia YF, Xiao DJ, Ma XL, Song YY, Hu R, Kong Y, Zheng Y, Han SY, Hong RL, Wang YS.

Diagn Pathol. 2013 Feb 27;8:37. doi: 10.1186/1746-1596-8-37.

31.
32.

Factors impacting prognosis prediction in BCLC stage C and Child-Pugh class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy.

Lin ZZ, Hsu C, Hu FC, Shao YY, Chang DY, Yang CH, Hong RL, Hsu CH, Cheng AL.

Oncologist. 2012;17(7):970-7. doi: 10.1634/theoncologist.2011-0411. Epub 2012 Jun 6.

33.

The cGMP signaling pathway affects feeding behavior in the necromenic nematode Pristionchus pacificus.

Kroetz SM, Srinivasan J, Yaghoobian J, Sternberg PW, Hong RL.

PLoS One. 2012;7(4):e34464. doi: 10.1371/journal.pone.0034464. Epub 2012 Apr 26.

34.

Osteoradionecrosis of the upper cervical spine after radiation therapy for head and neck cancer: differentiation from recurrent or metastatic disease with MR imaging.

Wu LA, Liu HM, Wang CW, Chen YF, Hong RL, Ko JY.

Radiology. 2012 Jul;264(1):136-45. doi: 10.1148/radiol.12111714. Epub 2012 Apr 10.

PMID:
22495686
35.

Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 study.

Urba S, van Herpen CM, Sahoo TP, Shin DM, Licitra L, Mezei K, Reuter C, Hitt R, Russo F, Chang SC, Hossain AM, Frimodt-Moller B, Koustenis A, Hong RL.

Cancer. 2012 Oct 1;118(19):4694-705. doi: 10.1002/cncr.27449. Epub 2012 Mar 20.

36.

Clinicopathological features of salivary and non-salivary adenoid cystic carcinomas.

Lin YC, Chen KC, Lin CH, Kuo KT, Ko JY, Hong RL.

Int J Oral Maxillofac Surg. 2012 Mar;41(3):354-60. doi: 10.1016/j.ijom.2011.12.022. Epub 2012 Jan 9.

PMID:
22230288
37.

Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer.

Chua DT, Yiu HH, Seetalarom K, Ng AW, Kurnianda J, Shotelersuk K, Krishnan G, Hong RL, Yang MH, Wang CH, Sze WK, Ng WT.

Head Neck. 2012 Sep;34(9):1225-30. doi: 10.1002/hed.21884. Epub 2011 Nov 11.

PMID:
22076785
38.
39.

Postoperative intensity-modulated radiotherapy for squamous cell carcinoma of the external auditory canal and middle ear: treatment outcomes, marginal misses, and perspective on target delineation.

Chen WY, Kuo SH, Chen YH, Lu SH, Tsai CL, Cheng JC, Hong RL, Chen YF, Hsu CJ, Lin KN, Ko JY, Lou PJ, Wang CP, Chong FC, Wang CW.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1485-93. doi: 10.1016/j.ijrobp.2011.05.018. Epub 2011 Jul 19.

PMID:
21775071
40.

A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor.

Yang SH, Lin CC, Lin ZZ, Tseng YL, Hong RL.

Invest New Drugs. 2012 Feb;30(1):282-9. doi: 10.1007/s10637-010-9522-3. Epub 2010 Sep 1.

PMID:
20809205
41.

Pleural metastases as a unique entity with dismal outcome of head and neck squamous cell carcinoma.

Shao YY, Hong RL.

Oral Oncol. 2010 Sep;46(9):694-7. doi: 10.1016/j.oraloncology.2010.06.014. Epub 2010 Aug 23.

PMID:
20739213
42.

The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients.

Yen RF, Chen CY, Cheng MF, Wu YW, Shiau YC, Wu K, Hong RL, Yu CJ, Wang KL, Yang RS.

Nucl Med Commun. 2010 Jul;31(7):637-45. doi: 10.1097/MNM.0b013e3283399120.

PMID:
20389259
43.

Dual roles of the bZIP transcription factor PERIANTHIA in the control of floral architecture and homeotic gene expression.

Maier AT, Stehling-Sun S, Wollmann H, Demar M, Hong RL, Haubeiss S, Weigel D, Lohmann JU.

Development. 2009 May;136(10):1613-20. doi: 10.1242/dev.033647.

44.

Nasion swelling as the presenting symptom of lung adenocarcinoma.

Huang CT, Hong RL.

J Thorac Oncol. 2009 Apr;4(4):555-8. doi: 10.1097/JTO.0b013e3181949f30. Review.

45.

Usefulness of 201TL SPECT/CT relative to 18F-FDG PET/CT in detecting recurrent skull base nasopharyngeal carcinoma.

Yen RF, Ting LL, Cheng MF, Wu YW, Tzen KY, Hong RL.

Head Neck. 2009 Jun;31(6):717-24. doi: 10.1002/hed.21026.

PMID:
19189341
46.

The cost-utility analysis of 18-fluoro-2-deoxyglucose positron emission tomography in the diagnosis of recurrent nasopharyngeal carcinoma.

Yen RF, Yen MF, Hong RL, Tzen KY, Chien CR, Chen TH.

Acad Radiol. 2009 Jan;16(1):54-60. doi: 10.1016/j.acra.2008.06.012.

PMID:
19064212
47.

Fatal thrombocytopenia after oxaliplatin-based chemotherapy.

Shao YY, Hong RL.

Anticancer Res. 2008 Sep-Oct;28(5B):3115-7.

48.

Natural variation in Pristionchus pacificus insect pheromone attraction involves the protein kinase EGL-4.

Hong RL, Witte H, Sommer RJ.

Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7779-84. doi: 10.1073/pnas.0708406105. Epub 2008 May 28.

49.

Species-specific recognition of beetle cues by the nematode Pristionchus maupasi.

Hong RL, Svatos A, Herrmann M, Sommer RJ.

Evol Dev. 2008 May-Jun;10(3):273-9. doi: 10.1111/j.1525-142X.2008.00236.x.

PMID:
18460089
50.

Supplemental Content

Support Center